Become A Sponsor
CTRP, Ctrip.com Nose Diving $4.20 (12.2%) to $30.08 on Weak Q4 Guidance | Kudrna's Stock Market Talk
In An Effort To Bring More Diversified Content To Our Readers.....Welcome Our New Authors To KSMT.....BreakoutTrader, TIPSTER, and Ryan Canady......Profiles Can Be Viewed On Right Column
Featured Articles
1 2 3 4 5 6 7 8 9 10
Seeking Alpha Certified 36,000+ Following KSMT And GROWING! Click To Join For Free!
avatar
CTRP, Ctrip.com Nose Diving $4.20 (12.2%) to $30.08 on Weak Q4 Guidance by | This entry was posted on Monday, November 14th, 2011 and filed under Stock Market   Comments Off


Price change: Ctrip.com (CTRP) is plunging down $4.20 (12.2%) to $30.08 on Weak Q4 Guidance.

Thesis: CTRP is often referred to as the “Expedia” of China. They provide hotel accommodations and airline tickets in China, but even a strong Q3 is not helping the stock today.

Bottom line: CTRP had better than expected earnings coming in at $.43 vs expectations of $.31. Their revenues were also strong as $153 million vs expectations of $150.8 million. However, they issued a weak Q4 guidance and expect revenues in that time period to come in at $143 million. Ctrip.com also had $8.5 million of government subsidies and without the help of the government, they would have missed their earnings on top and bottom line. The stock has not traded these levels since October 2009 with the December 28 Puts being the most active option trading around 2,000 contracts today. I do not have a position in this stock just yet and want to see how in reacts at the $30 level. They also received a slew of downgrades after a tough guidance report.

Kudrna's Stock Market Talk

Similar Posts:

    None Found

More on this topic (What's this?) Read more on Ctrip.com International at Wikinvest
FacebookDeliciousDiggGoogle GmailLinkedInStumbleUponTumblrRedditAOL MailMessengerPrintFriendlyYahoo MailYahoo MessengerYahoo BookmarksTechnorati FavoritesGoogle ReaderGoogle BookmarksBlogger PostAIMFavoritenPrintWordPressHotmailEmailRead It LaterShare

Tags:

Comments are closed.

Sponsor Ad

>